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Abstract
Background—The leading cause of asthma exacerbation is respiratory viral infection. Innate
antiviral defense pathways are altered in the asthmatic epithelium, yet involvement of
inflammasome signaling in virus-induced asthma exacerbation is not known.
Objective—To compare influenza-induced activation of inflammasome and innate immune
signaling in human bronchial epithelial cells from asthmatics and non-asthmatics and investigate
the role of caspase-1 in epithelial cell antiviral defense.
Methods—Differentiated primary human bronchial epithelial cells from asthmatics and non-
asthmatics were infected with influenza A virus. An inflammasome-specific quantitative real-time
polymerase chain reaction array was used to compare baseline and influenza-induced gene
expression profiles. Cytokine secretion, innate immune gene expression, and viral replication were
compared between human bronchial epithelial cells from asthmatics and non-asthmatics.
Immunofluorescence microscopy was used to evaluate caspase-1 and PYCARD co-localization.
Tracheal epithelial cells from caspase-1 deficient or wildtype mice were infected with influenza
and assessed for antiviral gene expression and viral replication.
Results—Human bronchial epithelial cells from asthmatics had altered influenza-induced
expression of inflammasome-related and innate immune signaling components, which correlated
with enhanced production of interlukin-1β, interleukin-6, and tumor necrosis factor-α.
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Specifically, influenza-induced caspase-1 expression was enhanced and localization differed in
human bronchial epithelial cells from asthmatics compared to non-asthmatics. Influenza-infected
tracheal epithelial cells from caspase-1 deficient mice had reduced expression of antiviral genes
and viral replication.
Conclusion—Caspase-1 plays an important role in the airway epithelial cell response to
influenza infection, which is enhanced in asthmatics and may contribute to the enhanced influenza
related pathogenesis observed in vivo.
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Introduction
Most acute asthma exacerbations are caused by respiratory viral infections and the resulting
innate immune response (1–6). Epidemiological studies of the 2009 H1N1 influenza A virus
(IAV) pandemic revealed an association between asthma diagnosis and increased morbidity
and mortality from infection, yet the mechanisms by which underlying asthma enhances
IAV-induced responses are poorly understood (7–10).
The primary sites for IAV infections are airway epithelial cells (AECs). The first step in the
AEC response to viral infections is recognition of the virus by pattern recognition receptors
(PRRs), such as NOD-like receptors (NLRs) and RIG-I- like receptors (RLRs), which
activate downstream signaling cascades to initiate expression of cytokines and
chemokines(11, 12). Several NLRs and RIG-I that oligomerize with caspase-1 and PYCARD
to form the inflammasome complex have been implicated in the innate immune response to
viruses, including IAV (12, 13). Formation of the inflammasome complex induces auto-
activation of caspase-1, which catalyzes the proteolytic processing of pro-IL-1β and pro-
IL-18. Active caspase-1 may also participate in several alternative mechanisms, including a
pro-inflammatory form of programmed cell death termed pyroptosis (14). Alterations in
inflammasome signaling are associated with inflammatory diseases including Crohns’
disease, gout, and atopic dermatitis (15); however, involvement of the inflammasome in
virus-induced asthma exacerbation is unknown.
Human bronchial epithelial cells (HBEC) from asthmatics have modified innate immune
responses to viral infection. A genome-wide expression study comparing rhinovirus (RV)-
infected HBEC from asthmatics and non-asthmatics demonstrated that HBEC from
asthmatics had altered RV-induced expression of immune response genes, including
IL1B (16). In addition, HBEC from asthmatics have been shown to have deficient RV-
induced interferon (IFN) production (17, 18) and increased production of the inflammatory
cytokines IL-6, IL-8, and GM-CSF with RSV infection(19), correlating with the increased
pro-inflammatory response to viral infections seen in vivo(20).
Since inflammasome signaling is important for antiviral response to IAV in AECs (21), and
virus-induced IL-1β expression differs in HBEC from asthmatics and non-asthmatics (16),
we hypothesized that in the asthmatic epithelium, altered expression of inflammasome and
innate immune signaling components contributes to virus-induced asthma pathogenesis.
Using differentiated primary HBEC, we compared IAV-induced activation of
inflammasome and innate immune responses in HBEC from asthmatics and non-asthmatics.
Our data show that IAV-induced expression of inflammasome and innate immune signaling
components is enhanced in HBEC from asthmatics. Specifically, caspase-1 expression and
localization differed in IAV-infected HBEC from asthmatics and associated with enhanced,
albeit low levels, of IAV-induced IL-1β production. Using tracheal epithelial cells (MTEC)
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from caspase-1 deficient (Casp1 −/−) mice, we found that caspase-1 affects expression of
several innate immunity genes and viral replication. Our results demonstrate an important
role for caspase-1 in the response to IAV infection at the level of the epithelium, which may
be independent of IL-1β production and is enhanced in HBEC from asthmatics.
Methods
Human bronchial epithelial cell (HBEC) culture
Primary HBEC were obtained from non-asthmatic (n=11) and asthmatic (n=13) adult
volunteers by cytologic brushing during bronchoscopy using a protocol approved by the
UNC-Chapel Hill School of Medicine Institutional Review Board. Refer to the online
repository for subject characterization information (Table E1–E3). Mild asthma status was
characterized by history of asthma symptoms (e.g. cough or wheeze) two times or less a
week and no current use of inhaled steroids. All asthmatics were considered “mild” except
for one, which was considered “moderately asthmatic” due to use of an oral steroid. Non-
asthmatics had no history of asthma symptoms. HBEC were expanded to passage two in
bronchial epithelial growth medium (BEGM; Cambrex Bioscience Walkersville, Inc.,
Walkersville, MD) and differentiated as described before (22).
Animals and murine tracheal epithelial cell (MTEC) isolation
C57BL/6 Casp1 −/− mice were purchased from Jackson Laboratories (Bar Harbor, ME).
Female 6–8 weeks old Casp1 −/− or wildtype matched littermates were used throughout the
study. All experimental procedures were approved by the University of North Carolina
Institutional Animal Care and Use Committee. MTEC isolation and culture was performed
as described by You et al. (23). MTEC were expanded to passage one in Ham’s F-12 medium
(Invitrogen, Carlsbad, CA) before use.
Influenza infection
HBEC were infected with Influenza A/Bangkok/1/79 (H3N2)(24–25) diluted in Hank’s
Buffered Saline Solution (HBSS, Invitrogen). MTEC were infected with mouse-adapted
Influenza A/PR/8/34 (H1N1)(26–27) diluted in culture medium. Both viruses were obtained
from Dr. Melinda Beck (Department of Nutrition, University of North Carolina, Chapel
Hill), propagated in 10-day-old embryonated hens’ eggs, and collected from the allantoic
fluid. For infection of HBEC and MTEC, 500,000 cells were infected with approximately 50
hemagglutination units (HAU). Control treated HBEC received HBSS alone, and MTEC
received media alone.
Quantitative real-time PCR (qRT-PCR)
Total RNA was isolated from HBEC from asthmatics (n=7) and non-asthmatics (n=8) using
TRizol (Invitrogen) according to manufacturer instructions. First-strand cDNA synthesis and
qRT-PCR were performed as previously described (28, 29). Refer to online repository for
primer/probes. Differences in expression were determined using the Ct method and B-actin
for normalization.
qRT-PCR array
Total RNA isolated from a subset of HBEC from asthmatics (n=3) and non-asthmatics (n=3)
was purified using an RNeasy Mini Kit (Qiagen, Valencia, CA). cDNA was prepared using
a RT First Strand Kit (SABiosciences, Frederick, MD) and analyzed using the human
inflammasome RT2 Profiler PCR Array System (SABiosciences). Gene expression results
were normalized to GAPDH, analyzed using the ΔΔCt method, and probed for genes with
≤1.5-fold difference in expression.
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The apical surface of HBEC were washed with HBSS and analyzed for concentrations of
IL-6, IL-1β, and TNFα using a commercially available ELISA kit (Meso Scale Discovery,
Gaithersburg, MD). Lower limits of detection were: IL-1β= 0.5 pg/ml; IL-6= 0.22 pg/ml;
TNFα= 0.49 pg/ml.
Immunofluorescence microscopy
HBEC from asthmatics (n=3) and non-asthmatics (n=3) were fixed with 4%
paraformaldehyde (Sigma-Aldrich) and prepared for immunofluorescence as described
previously (30). See online repository for caspase-1 and PYCARD antibody information. A
Nikon C1si confocal microscope with a 60x oil lens and Nikon EZ-C1 3.8 software were
used to acquire z-stack images (Nikon Instruments, Melville, NY), which were processed
using the NIS-Elements software (Nikon). Images shown are composites of all z-stack
slices. Equal adjustments were performed on all images..
Influenza virus titer
Influenza virus titers in apical washes (HBEC) or supernatants (MTEC) were determined by
50% tissue culture infections dose (TCID50) in Madin-Darby canine kidney cells (MDCK)
and by hemagglutination as previously described (31).
Statistical analysis
Array results were analyzed using the Comparative Marker Selection tool in GenePattern
(www.broadinstitute.org/cancer/software/genepattern/)(32). Refer to online repository for
additional array analysis. For gene expression, cytokine analysis, and viral titer data,
individual differences between asthmatics and non-asthmatics or Casp1−/− and wildtype
mice were assessed by analysis of variance (ANOVA) with a Tukey post-hoc test (*p <
0.05, ** p< 0.01, ***p < 0.001). Factorial ANOVA was used to determine the interaction
between IAV infection and asthma status or mouse genotype (# p<0.05, ## p< 0.01, and ###
p<0.001). Endpoints with no detection at baseline (MTEC IL-6 and M1 expression and viral
titer) were assessed using unpaired T-test for individual differences between Casp1 −/− and
wildtype MTEC 24 hours post-IAV infection (@ p<0.05). All graphs show mean ± SEM.
Results
HBEC from asthmatics have enhanced IAV-induced production of cytokines
To determine whether HBEC from asthmatics have altered IAV-induced cytokine
production, HBEC from asthmatics and non-asthmatics were infected with IAV for 6 or 24
hours and assessed for cytokine secretion (Figure 1A–C; Table E4–E5, Online Repository).
HBEC from asthmatics secreted significantly more IAV-induced IL-6, TNFα, and IL-1β,
with the greatest increase observed 24 hours post-infection. Notably, the subject
characterized as “moderately asthmatic” (Table E1, Online Repository) had neither an
ablated nor a particularly heightened response to IAV infection.
HBEC from asthmatics have differential expression of inflammasome- and innate
immunity-related genes
Based on the elevated production of IL-1β by HBEC from asthmatics (Figure 1A), we
investigated alterations in inflammasome signaling. Using an inflammasome-specific qRT-
PCR array, encompassing 84 genes involved in innate immunity and inflammasome
signaling, we compared baseline and IAV-induced gene expression between HBEC from
asthmatics and non-asthmatics (Table 1 and Table E6, Online Repository for full array data).
The expression of eight genes was significantly altered at baseline in HBEC from asthmatics
Bauer et al. Page 4













(Table 1). Of these genes, all but CCL5 were down-regulated in HBEC from asthmatics. 24
hours post-IAV infection, HBEC from asthmatics had altered expression of seventeen genes,
all of which were enhanced (Table 1).
To confirm and expand upon the array results, we performed gene-specific qRT-PCR
analysis of several genes with significant differences in HBEC from asthmatics using an
increased number of subjects and expanded time course. Similar to the array results, HBEC
from asthmatics had significantly increased expression of CASP1, CASP4, RIPK2, NLRC5,
and NOD2 after IAV infection (Figure 2A, C–F). The greatest increase was observed 24
hours post-IAV infection, correlating with the highest production of cytokines. In both
HBEC from asthmatics and non-asthmatics, the expression of PYCARD, an adaptor protein
which links caspase-1 to one of several inflammasome receptors, was initially reduced with
IAV infection, and then returned to baseline levels by 24 hours post-infection (Figure 2B).
The expression of PYCARD was slightly decreased in HBEC from asthmatics throughout
the time course, correlating with the array results.
Caspase-1 and PYCARD immunofluorescence microscopy
Inflammasome signaling involves the oligomerization of caspase-1, PYCARD, and a PRR to
form the inflammasome complex. To determine whether IAV- induced expression of
caspase-1 translates to caspase-1/PYCARD co-localization, we used immunofluorescence
microscopy to qualitatively assess the localization of PYCARD and caspase-1 in HBEC
from asthmatics and non-asthmatics 6 or 24 hours post-IAV infection (Figure 3, and Figures
E2–E3, Online Repository). In both groups at baseline, caspase-1 and PYCARD were
located diffusely throughout the cell (Figure 3A–B 1st and 3rd rows, E2A-B 1st row). With
IAV infection, we observed the formation of co-localized caspase-1/PYCARD foci,
especially in the asthmatics, and particularly at 24 hours post-IAV infection (Figure 3A–B
2nd and 4th rows, E2A–B 2nd row). The HBEC from asthmatics had large, intense foci of co-
localized PYCARD and caspase-1 at 24 hours post-IAV infection, (Figure 3A 4th row, E2A
2nd row), correlating with the enhanced caspase-1 expression 24 hours post-IAV infection
(Figure 2A). The co-localization of caspase-1 and PYCARD did not correlate with
cytotoxicity, as we did not detect any differences in cytotoxicity throughout the infection
time course (Figure E1, Online Repository). Our data show that PYCARD and caspase-1 co-
localized in response to IAV infection in HBEC, and suggests that the intensity of co-
localization appears to differ in HBEC from asthmatics.
HBEC from asthmatics have increased expression of antiviral genes, which correlates with
enhanced IAV replication
We next investigated whether HBEC from asthmatics also had enhanced expression of
known antiviral genes, particularly interferon-γ induced protein 10 (IP-10), interferon β
(IFNβ) and retinoic acid inducible-gene I (RIG-I). Our data show that HBEC from
asthmatics had elevated expression of these genes 24 hours post-IAV infection (Figures 4A–
C).
To determine whether the enhanced innate immune response was due to increased viral
replication, we assessed influenza hemagglutinin (HA) transcripts and TCID50 viral titers of
HBEC from asthmatics and non-asthmatics(24, 33). Though HBEC from asthmatics had no
significant overall differences compared to non-asthmatics (Figures 5), there was significant
correlation between the expression of IP-10, IFNβ, and RIG-I and influenza HA transcript
number, suggesting that the enhanced innate immune response in the HBEC from asthmatics
was correlated with greater viral replication (Figure E4A–C, Online Repository). Likewise,
caspase-1 expression was correlated with influenza HA mRNA levels, suggesting that
caspase-1 is involved in the antiviral response (Figure E4D, Online Repository).
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MTEC from Casp1−/− mice have diminished antiviral response to IAV infection and
reduced viral replication
Our findings in HBEC from asthmatics indicated the enhanced expression of caspase-1 was
associated with heightened innate immune response to IAV. To further assess whether
caspase-1 was causally linked to antiviral defense against IAV infection, we examined the
expression of innate immune genes by MTEC from Casp1 −/− and wildtype mice, which
were cultured and infected with IAV ex vivo. Our results show that Casp1 −/− MTEC had
reduced IAV-induced expression of IFNα, IFNβ, IL-6, and IP-10 compared to wildtype
(Figure 6), suggesting that the presence of caspase-1 is necessary for optimal expression of
these genes. The baseline and IAV-induced expression of RIG-I was decreased to a similar
extent in Casp1 −/− MTEC, suggesting that caspase-1 expression may regulate baseline
expression of RIG-I, and that these effects persist during IAV infection.
To determine whether decreased viral replication was associated with the diminished innate
immune gene expression response in Casp1−/− MTEC, we assessed viral replication 24
hours post-IAV infection. Compared to wildtype, the Casp1 −/− MTEC had reduced levels
of influenza matrix 1 (M1) RNA and lower viral titers (Figure 7). To determine if viral
replication was necessary for the diminished innate immune gene expression response in
Casp1 −/− MTEC, wildtype and Casp1 −/− MTEC were infected with UV-inactivated
(replication deficient) IAV, wildtype IAV, or media control and assessed for expression of
IP-10, which had the most robust IAV-induced expression (Figure 6), and influenza M1
RNA (Figure E5, Online Repository). No M1 transcripts were detected from cells infected
with UV-inactivated IAV. As observed in Figure 6, wildtype-IAV infected Casp1 −/−
MTEC had significantly lower IP-10 expression compared to wildtype MTEC. When
infected with UV-inactivated virus, the Casp1 −/− and wildtype MTEC had similar
expression levels of IP-10, suggesting that viral replication was necessary for the diminished
innate immune gene expression in Casp1 −/− MTEC.
Discussion
Respiratory viral infections are the leading cause of asthma exacerbations. Innate antiviral
defense pathways are altered in the asthmatic epithelium, yet involvement of the
inflammasome in virus-induced asthma exacerbations is unknown. We compared IAV-
induced activation of inflammasome and innate immune signaling between differentiated
HBEC from asthmatics and non-asthmatics, and found that HBEC from asthmatics had
modified baseline and IAV-induced expression of genes involved in innate immune and
inflammasome signaling. In particular, we showed that caspase-1 expression was enhanced
in HBEC from asthmatics, correlating with enhanced, albeit low levels, of IAV-induced
IL-1β production. Using MTEC from Casp1 −/− and wildtype mice, we found that IAV-
infected Casp1 −/− MTEC had decreased expression of innate immunity genes and viral
replication compared to wildtype. These results establish an important role for caspase-1 in
the AEC response to IAV, which may involve inflammasome-independent functions and is
enhanced in the asthmatic epithelium.
AEC-derived cytokines and chemokines contribute to the inflammatory cell influx and
airway hyperresponsiveness associated with asthma exacerbation. AECs from asthmatics
have altered production of cytokines and chemokines in response to RV and RSV (16, 17, 19).
Consistent with these observations, we found that baseline and/or IAV-induced levels of
innate immune cytokines and chemokines (IL-1β, TNFα, IL-6, CCL5, IP-10, and β) were
enhanced inIFN HBEC from asthmatics. Previous studies have shown that these cytokines
are increased in asthmatic airways in vivo either at baseline or following challenge and
contribute to virus-induced asthma exacerbation (34–39). Our findings add to the literature
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suggesting that baseline differences in HBEC from asthmatics may prime the epithelium for
an exaggerated innate immune response to viral infection.
Many of the cytokines and chemokines with enhanced expression in HBEC from asthmatics
are under NF-kB regulation. NF-kB activity has previously been shown to be enhanced in
AECs from asthmatics(40, 41). We found that expression of NFKBIB, an inhibitor of NF-kB
signaling, was reduced in HBEC from asthmatics at baseline (Table 1), which may
contribute to the enhanced innate immune response to IAV infection. Interestingly,
caspase-1 has been shown to activate NF-kB via RIPK2, a CARD-containing kinase(42) that,
similar to caspase-1, had enhanced IAV-induced expression in HBEC from asthmatics
(Table 1, Figure 2E). Additionally, Nod2 activation of NF-kB signaling has been shown to
induce CCL5 release in murine macrophages(43). Our findings indicate that IAV-induced
expression of Nod2 was enhanced in HBEC from asthmatics (Table 1, Figure 2D),
suggesting that Nod2 may be a regulator of IAV-induced CCL5 release that is enhanced in
HBEC from asthmatics.
The enhanced IAV-induced production of IL-1β suggested that HBEC from asthmatics may
have modified inflammasome activity. Other studies have demonstrated involvement of the
inflammasome and, more specifically, NOD-like receptor protein 3 (NLRP3), in defense
against IAV infection (21, 44, 45). Allen et al. found that AECs secrete IL-1β, albeit at much
lower concentrations than monocytes (21). We similarly observed low levels of IL-1β
secretion, suggesting that AECs are not a major source of this cytokine. Though the
canonical function of the inflammasome is activation of caspase-1 for the proteolytic
processing of pro-IL-1β and pro-IL-18, caspase-1 has alternative functions involved in the
activation of NF-kB signaling, cell death, cellular metabolism, and cell repair (14).
Therefore, caspase-1 may play alternative roles in non-myeloid cells, such as AECs, which
do not produce high levels of IL-1β.
Based on this knowledge, we used a less biased approach to identify inflammasome-related
pathways activated by IAV infection. The most consistent differences in IAV-induced gene
expression were the increased expression of CASP1 and CASP4 in HBEC from asthmatics.
Caspase-4, a member of the caspase-1 subfamily, is involved in inflammatory responses to
IAV infection (46–48). The murine homolog of caspase-4, caspase-11, may be involved in
caspase-1 activation and inflammasome-mediated cell death (49, 50).
Activation of the inflammasome pathway involves oligomerization of caspase-1 and
PYCARD with a PRR to form the inflammasome complex. The formation of large
caspase-1/PYCARD foci has previously been shown in macrophages and monocytes (51–53).
In resting monocytes and macrophages, PYCARD and caspase-1 exist diffusely throughout
the cell (50, 52). When stimulated by an agonist, PYCARD forms large cytosolic foci, which
are often associated with NLRs and caspase-1 (50). Using immunofluorescence microscopy,
we demonstrated IAV-induced co-localization of caspase-1 and PYCARD in HBEC. In
agreement with the gene expression and cytokine data, we observed large and intense
caspase-1 and PYCARD co-localization with IAV infection especially in asthmatics at 24
hours post-IAV infection.
Our findings in HBEC indicate that caspase-1 is involved in the innate immune response to
IAV infection. To further define the role of caspase-1 in antiviral defense, we infected
MTEC from Casp1 −/− and wildtype mice with IAV. Notably, the mouse-adapted influenza
virus influenza A/PR/8/34 strain was used to infect MTEC and may differ in infectivity
compared the human influenza A/Bangkok/1/79 strain. Our results indicate that IAV-
infected MTEC and HBEC had similar patterns of innate immune gene expression. We
found that 24 hours post-IAV infection, Casp1 −/− MTEC had decreased viral replication,
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correlating with reduced expression of several innate immune genes. Interestingly, enhanced
caspase-1 expression in HBEC was correlated with increased influenza HA transcript
quantity, suggesting that caspase-1 may be a determinate of viral replication. Previous
studies have shown that Casp1−/− mice infected in vivo with IAV had reduced quantities of
innate immune cytokines and chemokines in the bronchoalveolar lavage, which correlated
with increased severity of pneumonia and mortality (44). In contrast to our study, this study
did not detect a difference in lung viral titers measured at 3 or 6 days post-IAV infection.
Thus, though caspase-1 appears important for IAV-induced expression and secretion of
cytokines and chemokines, caspase-1 involvement in viral replication remains unclear.
Notably, the Casp-1 −/− mouse model also harbors a mutation in the Casp11 gene, rendering
the mice Casp1/Casp11 double knockouts (48). Our findings in HBEC show that expression
of caspase-4 (the human homolog of caspase-11) is up-regulated following IAV infection.
Future studies are necessary to delineate the functions of caspase-1 and caspase-4 in
antiviral response.
Though our results suggest that caspase-1 is important for the innate immune response to
IAV, whether caspase-1 activity is related to inflammasome complex formation remains
unclear. We were unable to detect expression of many NOD-like receptors by the qRT-PCR
array, including NLRP3, which was previously shown to be expressed in AECs following
IAV infection (21, 44). While protein expression cannot be excluded, these results indicate
that, in AECs, the NLRP3 inflammasome may play a less prominent role than caspase-1 and
other complexes in the response to IAV.
Our findings suggest that HBEC from asthmatics have an enhanced innate immune response
to IAV infection. We found that HBEC from asthmatics had baseline and virus-induced
differences in gene expression, and that enhanced innate immune gene expression correlated
with viral replication. However, we found no overall differences in viral replication. These
findings are consistent with a recent genome-wide expression study demonstrating that
HBEC from asthmatics have many baseline differences in gene expression also present in
cells with RV infection (16). Yet, this study and others using HBEC have shown either
enhanced or no difference in RV replication in asthmatics compared to non-
asthmatics (16, 17, 54). Therefore, HBEC from asthmatics may not necessarily have a more
severe viral load, but rather a more sensitive and severe innate immune response,
contributing to airway inflammation and pathogenesis.
Collectively, our results demonstrate that caspase-1 is important for the AEC innate immune
response to IAV infection, which is enhanced in HBEC from asthmatics. Similar to other
studies, our findings suggest that caspase-1 regulates the expression and secretion of
cytokines besides IL-1β and IL-18, and thus may have other non-inflammasome related
functions contributing to innate immunity (44). Since viral infections are the leading cause of
asthma exacerbations, understanding the contribution of modified innate immune
mechanisms to asthma pathogenesis is essential for the development of relevant therapies.
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CCL5 Chemokine (C-C motif) ligand 5
ELISA Enzyme-linked immunosorbent assay
GAPDH Glyceraldehyde 3-phosphate dehydrogenase
GM-CSF Granulocyte-macrophage colony-stimulating factor
HA hemagglutinin
HAU hemagglutination units
HBEC human bronchial epithelial cell
HBSS Hank’s buffered saline solution




Influenza HxNx Influenza Hemagglutinin x, Neuraminidase x
IP-10 Interferon gamma-induced protein 10
KC keratinocyte chemoattractant
M1 influenza matrix 1 protein
MDCK Madin Darby canine kidney
MIP-2 Macrophage inflammatory protein 2
MTEC mouse tracheal epithelial cells
NLR NOD-like receptor
NLRC5 NLR family, CARD domain containing 5
NLRP3 NLR family, pyrin domain containing 3
NOD Nucleotide-binding oligomerization domain
NOD2 Nucleotide-binding oligomerization domain protein 2
PRR pattern recognition receptor
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qRT-PCR quantitative real-time polymerase chain reaction
RIG-I retinoic acid-inducible gene 1 protein
RIPK2 Receptor-interacting serine/threonine-protein kinase 2
RLR RIG-I- like receptor
RSV respiratory syncytial virus
RV rhinovirus
SNR signal-to-noise
TCID50 50% tissue culture infectious dose
TLR Toll-like receptor
TNFα tumor necrosis factor alpha
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• The innate immune response to influenza virus infection is enhanced in human
bronchial epithelial cells from asthmatics, which may contribute to the
heightened influenza-related pathogenesis observed in asthmatics in vivo.
• Caspase-1 plays an important role in the innate immune response to influenza
virus infection in airway epithelial cells, and is enhanced in airway epithelial
cells from asthmatics, which may contribute to virus-induced asthma
pathogenesis.
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HBEC from asthmatics have enhanced production of pro-inflammatory cytokines in
response to IAV infection. Apical washes from HBEC from asthmatics (n=7) and non-
asthmatics (n=8) were collected 6 or 24 hours post-IAV infection or 24 hours HBSS control
treatment and analyzed for (A) IL-1β; (B) IL-6; and (C) TNFα concentrations by ELISA.
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Gene- specific qRT-PCR confirmation of inflammasome-related gene expression. Total
RNA from HBEC from asthmatics (n=7) and non-asthmatics (n=8) at 6 or 24 hours post-
IAV infection or 24 hours HBSS control treatment was analyzed for expression of (A)
CASP1; (B) PYCARD; (C) CASP4; (D) NOD2; (E) NLRC5; and (F) RIPK2 by qRT-PCR.
Ct values were normalized to β-actin.
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Caspase-1 and PYCARD co-localize with IAV-infection. HBEC from (A) asthmatics and
(B) non-asthmatics 6 or 24 hours post-IAV infection or HBSS control treatment were probed
for Caspase-1 (red) and PYCARD (green). DAPI stain identified nucleic acid (blue). Images
are representative of 3 asthmatic and 3 non-asthmatic isolates. White bars=10μm.
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HBEC from asthmatics have enhanced expression of antiviral genes. Total RNA from
HBEC from asthmatics ( n=7) and non-asthmatics ( n=8) at 6 or 24 hours post-IAV infection
or 24 hours HBSS control treatment was analyzed for expression of (A) IFNβ; (B) IP-10;
and (C) RIG-I by qRT-PCR. Ct values were normalized to β-actin.
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Viral replication is not significantly increased in HBEC from asthmatics. (A) Total RNA
from IAV-infected HBEC from asthmatics (n=7) and non-asthmatics (n=8) were analyzed
for IAV hemagglutinin (HA) RNA by qRT-PCR. Ct values were normalized to β-actin. (B)
Vial titer of apical washes from HBEC from asthmatics (n=4–5) and non-asthmatics (n=6) at
6 and 24 hours post-IAV infection.
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Casp1 −/− MTEC have diminished antiviral gene expression in response to IAV infection.
RNA from wildtype (n=8) and Casp1 −/− (n=9) MTEC 24 hours post-IAV infection or
control were analyzed for expression of (A) IFNα; (B) IFNβ; (C) RIG-I; (D) IL-6; (E) IP-10
by qRT-PCR. Ct values were normalized to β-actin. @ p<0.05 Student’s T-test Casp1 −/−
vs. wildtype, 24hrs post-IAV infection only; * p<0.05, **p<0.01; ***p<0.001 ANOVA and
Tukey post-hoc test, Casp1 −/− vs. wildtype 24hrs post-IAV and control infection;
##p<0.01, ### p<0.001 Factorial ANOVA, interaction between genotype and infection.
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CASP1 −/− MTEC have diminished viral replication. (A) Total RNA from Casp1 −/− (n=9)
and wildtype (n=8) MTEC 24 hours post-IAV infection or media control treatment were
analyzed for IAV matrix 1 (M1) RNA by qRT-PCR. Ct values were normalized to β-actin.
(B) Vial titer was assessed using media supernatents from Casp1 −/− (n=9) and wildtype
(n=8) MTEC 24 hours post-IAV infection.
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